Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
AstraZeneca
AstraZeneca
Sohag University
University of Wisconsin, Madison
TidalSense
Eurasian Association of Therapists
National Institutes of Health Clinical Center (CC)
Hong Kong Sanatorium & Hospital
Hospices Civils de Lyon
University of Wisconsin, Madison
Roxall Medicina España S.A
Bispebjerg Hospital
Weill Medical College of Cornell University
Weill Medical College of Cornell University
AstraZeneca
University Hospital Southampton NHS Foundation Trust